Search

Search Constraints

You searched for: Author/Creator Smylie, Michael

Search Results

5. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Issue 5 (May 2015)

10. Health-related quality of life results from the phase III CheckMate 067 study. (September 2017)